These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3329246)

  • 21. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new immunomodulator, FR-901235.
    Shibata T; Nishikawa M; Tsurumi Y; Takase S; Terano H; Kohsaka M
    J Antibiot (Tokyo); 1989 Sep; 42(9):1356-61. PubMed ID: 2793590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metacytofilin, a novel immunomodulator produced by Metarhizium sp. TA2759.
    Iijima M; Masuda T; Nakamura H; Naganawa H; Kurasawa S; Okami Y; Ishizuka M; Takeuchi T; Iitake Y
    J Antibiot (Tokyo); 1992 Sep; 45(9):1553-6. PubMed ID: 1429244
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo and in vitro macrophage activation by systemic adjuvants.
    Bruley-Rosset M; Florentin I; Mathé G
    Agents Actions; 1976 Feb; 6(1-3):251-5. PubMed ID: 782207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1683-8. PubMed ID: 4587143
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of Mycobacterium bovis BCG, bacterial lipopolysaccharide and hydrocortisone on the development of immunity to Plasmodium berghei.
    Ferraroni JJ; Douglass TG; Speer CA
    Rev Inst Med Trop Sao Paulo; 1986; 28(1):36-45. PubMed ID: 3532283
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
    Mazzantini RP; Miyaji EN; Dias WO; Sakauchi D; Nascimento AL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Vaccine; 2004 Jan; 22(5-6):740-6. PubMed ID: 14741167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.
    Arama C; Waseem S; Fernández C; Assefaw-Redda Y; You L; Rodriguez A; Radošević K; Goudsmit J; Kaufmann SH; Reece ST; Troye-Blomberg M
    Vaccine; 2012 Aug; 30(37):5578-84. PubMed ID: 21983157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of bacterial products on interferon production.
    Sonnenfeld G
    Methods Enzymol; 1994; 236():42-7. PubMed ID: 7968626
    [No Abstract]   [Full Text] [Related]  

  • 33. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.
    Vogel SN; Moore RN; Sipe JD; Rosenstreich DL
    J Immunol; 1980 Apr; 124(4):2004-9. PubMed ID: 6154089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolation of immunological adjuvant component from B.C.G. cells.
    Hiu IJ; Amiel JL
    Rev Eur Etud Clin Biol; 1971; 16(1):55-8. PubMed ID: 4929110
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-gamma or BCG restores the responsiveness of mouse lung macrophages to lipopolysaccharide.
    Tokunaga T; Akagawa KS
    Tokai J Exp Clin Med; 1986; 11 Suppl():89-96. PubMed ID: 3132756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.
    Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T
    J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemistry and biology of a hot water extract from delipidated Mycobacterium bovis, strain BCG.
    Yokosawa A
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):65-82. PubMed ID: 379996
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the endotoxin induced tumor resistance.
    Nowotny A; Butler RC
    Adv Exp Med Biol; 1979; 121B():455-69. PubMed ID: 397758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.